IDO1 and neoplasm: IDO1 is expressed in multiple tumor types and is associated with reduced activation of cytotoxic cells, increased infiltration of tumor-regulating T-cells, poorer survival rates [49,50,51,52,53,54,55], and increased drug resistance [56,57,58,59].